M García‐Bustínduy
Hospital Universitario de Canarias
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M García‐Bustínduy.
Clinical and Experimental Dermatology | 2005
M Sáez; Marina Rodríguez-Martín; Miriam Sidro; Ana Carnerero; M García‐Bustínduy; Antonio Noda
bined with topical or systemic anti-infective agents, dermabrasion, CO2 laser vaporization and Grenz ray therapy. Full-thickness excision of affected skin with repair by split-thickness grafting may reduce sweating and provide improvement. Dapsone, vitamin E, psoralen ultraviolet A, methotrexate, or thalidomide have been recommended. Infection is a common complication, and in disease exacerbation several infective causes (bacterial ⁄ fungal ⁄ viral) need to be excluded. Although our patient was treated with Fucibet ointment with no improvement, this did not exclude an underlying fungal infection. When he presented to us, apart from lesions consistent with Hailey–Hailey disease there was also evidence of tinea pedis and widespread fungal infection (tinea incognito). Our patient was commenced on oral lamisil and topical ketoconazole ointment with reduced usage of topical steroids in the infected areas, and improved after treatment.
British Journal of Dermatology | 2004
F. Guimerá‐Martín‐Neda; M García‐Bustínduy; Antonio Noda-Cabrera; Rosalba Sánchez-González; R.G. Montelongo
1 Fujimoto N, Tajima S, Ishibashi A. Facial lichen striatus: successful treatment with tacrolimus ointment. Br J Dermatol 2003; 148: 587–90. 2 Sorgentini C, Allevato MA, Dahbar M, Cabrera H. Liquen estriado del adulto. Tratamiento con tacrolimus tópico. Actualizaciones Terapéuticas Dermatológicas y Estéticas 2003; 26: 44–50. 3 Taieb A, el-Youbi A, Grosshans E, Maleville J. Lichen striatus: a Blaschko linear acquired inflammatory skin eruption. J Am Acad Dermatol 1991; 25: 637–42. 4 Michel JL, Wolf F, Fond L, Cambazard F. Lichen striatus in children and blaschkitis in adults. Ann Dermatol Venereol 1997; 124: 187– 91. 5 Kaliakatsou F, Hodgson TA, Lewsey J et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002; 46: 35–41.
Journal of The European Academy of Dermatology and Venereology | 2006
M Sáez; Marina Rodríguez-Martín; M Sidro‐Sarto; R Cabrera de Paz; F Rodríguez‐García; E Fagundo‐González; A Carnerero; Francisco Guimerá; M García‐Bustínduy; Roel Sánchez; A Martín Herrera; Antonio Noda
356 JEADV 2006, 20, 341–362
Dermatology | 2002
M Sáez; M García‐Bustínduy; Antonio Noda; F.J. Guimerá; Sara Dorta; M. Escoda; E. Fagundo; Rosalba Sánchez; A. Martín-Herrera; R. García Montelongo
All criteria for drug-induced Sweet’s syndrome are fulfilled by our patient. Only a single case in which Sweet’s syndrome was believed to be precipitated by oral contraceptives could be found. Nevertheless as more cases of drug-induced Sweet’s syndrome are being reported in the literature we suggest that a drug aetiology should be sought in cases of Sweet’s syndrome and we recommend that a careful drug history should be included in the assessment of all the cases of this syndrome. (excerpt)
Journal of The European Academy of Dermatology and Venereology | 2004
M García‐Bustínduy; M Escoda; Francisco Guimerá; M Sáez; S Dorta; E. Fagundo; Rosalba Sánchez-González; Antonio Noda-Cabrera; R García‐Montelongo
Background An intermittent short course of cyclosporin A (CyA) therapy is a good choice in the treatment of severe psoriasis. Nevertheless, some severe or resistant patients might benefit from long‐term treatment. Adverse effects of long‐term use of CyA are investigated and the results are compared with the literature.
Journal of The European Academy of Dermatology and Venereology | 2002
Miguel Sáez-Rodríguez; Antonio Noda-Cabrera; S Álvarez‐Tejera; F Guimerá‐Martín‐Neda; S Dorta‐Alom; M Escoda‐García; E Fagundo‐González; Rosalba Sánchez-González; R García‐Montelongo; M García‐Bustínduy
Objective The aim of the present study was to find out whether emotional stress is related to palmoplantar pustulosis (PPP).
Clinical and Experimental Dermatology | 2007
Marina Rodríguez-Martín; Miguel Sáez-Rodríguez; A Carnerero-Rodríguez; R Cabrera de Paz; M Sidro‐Sarto; N. Pérez‐Robayna; Rosalba Sánchez; M García‐Bustínduy; Antonio Martín-Herrera; Antonio Noda-Cabrera
T.Yanagi, N. Kato, N. Yamane, R. Osawa, K. Isu* and W. Ichimura† Departments of Dermatology, *Orthopaedic Surgery and Department of †Radiology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. Dr Teruki Yanagi, MD, Department of Dermatology, National Hospital Organization Hokkaido Cancer Center, Kikusui 4-2, Shiroishi-ku, 0030804, Sapporo, Japan. E-mail: [email protected] Conflict of interest: none declared. Accepted for publication 29 January 2007
British Journal of Dermatology | 2000
S. Dorta; R. Sánchez; M García‐Bustínduy; F. Guimerá; M. sáez; A. Noda; Antonio Martín-Herrera; R. García-Montelongo
q 2000 British Association of Dermatologists, British Journal of Dermatology, 143, 892±918 7 ToÈroÈk L, Tapai M. EntzuÈ ndungsreaktion beim Melanom. H1G 1993; 68: 459±62. 8 Tan BB, Mardsen JR, Sanders DAS. Melanoma erysipeloides: inflammatory metastatic melanoma of the skin. Br J Dermatol 1993; 129: 327±9. 9 BoÈni R, Meuli C, Dummer R. Erysipelas melanomatosum. Br J Dermatol 1997; 137: 833±4. 10 Klimpel M. Atypisches Erysipelas melanomatosum. H1G 1982; 57: 783±8. 11 Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol 1996; 43: 798±803. 12 Legha SS. The role of interferon-alfa in the treatment of metastatic melanoma. Semin Oncol 1997; 24 (Suppl. 4): 24±31. 13 Thompson JA, Gold PJ, Fefer A. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma. Semin Oncol 1997; 24 (Suppl. 4): 44±8. 14 Ron IG, Mordish Y, Eisenthal A et al. A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-a2a in patients with advanced malignant melanoma. Cancer Immunol Immunother 1994; 38: 379±84. 15 Johnson TM, Smith JW, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32: 689±707.
Journal of Cutaneous Pathology | 1999
M García‐Bustínduy; Hugo Álvarez-Argüelles; Francisco Guimerá; Candelaria Garcia-Castro; Rosalba Sánchez-González; Norberto Hernandez; Lucio Díaz-Flores; R García‐Montelongo
Only a few reports of primary cutaneous rhabdoid tumors have been published. We describe the case of a 3‐month‐old female patient who developed a rhabdoid type cutaneous sareomatoid neoplasm in her upper back, close to a benign myofibromatous proliferation of infancy. The lesion was studied both by light microscopy and immunohisto‐chemically. Flow cytometry was performed showing a DNA diploid profile of the malignant tumor. The pathological findings suggest a mesenchymal origin (hemangiopericytic or myofibroblastic type) for both tumors. The patient was surgically treated, but she died nine months later.
Journal of The European Academy of Dermatology and Venereology | 2008
M Sidro‐Sarto; F Guimerá‐Martín‐Neda; Nuria Pérez-Robayna; S Gonzalez; M García‐Bustínduy; Antonio Noda; Rosalba Sánchez-González
© 2008 The Authors 1517 JEADV 2008, 22, 1497–1524 Journal compilation